


NEUROBIOMAT
Biotechnology Research • Archamps, Auvergne-Rhône-Alpes, France • 1-10 Employees
Company overview
| Headquarters | 72 RUE GEORGES DE MESTRAL - ATHENA 1 -, Archamps, Auvergnerhônealpes 74160, FR |
| Phone number | +3304508760 |
| Website | |
| NAICS | 541714 |
| Keywords | Biotechnology, Medical Device, Regenerative Medicine, Neurosurgery, Neurotechnology, Nervous System, Dispositif Médical, Hydrogel, Paraplegia, Functional Recovery, Spinal Injuries, Tissue Repair, Système Nerveux, Médecine Régénérative, Cure Paraplegia, Neural Tissue Repair, Spinal Cord Reconstruction, Spinal Cord Trauma |
| Founded | 2018 |
| Employees | 1-10 |
Key Contact at NEUROBIOMAT
Stéphane Woerly Md Phd
Founding President (CSO&CMO)
NEUROBIOMAT Email Formats
NEUROBIOMAT uses 2 email formats. The most common is {first initial}.{second initial} (e.g., j.o@neurobiomat.com), used 66.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{second initial} | j.o@neurobiomat.com | 66.7% |
{first initial}.{last name} | j.doe@neurobiomat.com | 33.3% |
About NEUROBIOMAT
SPINAL CORD INJURY Spinal cord injury is a serious trauma that affects more than 2M people worldwide. The spinal cord is made up of nerve bundles that receive voluntary motor commands from the brain to the limbs and it is through this channel that the perception of sensitivities is transmitted to the brain (touch, temperature, position, pain). Disabilities can occur when an injury to the spinal cord damages the wiring responsible for transmitting these nerve impulses. The trauma affects the motor and sensory functions of the patient and paralysis sets in without any possibility of full recovery or returning to one's physical state before the accident. Today, there is currently no treatment to overcome this paralysis and restore nerve sensitivity or the ability to walk again. INNOVATIVE NEUROTECHNOLOGY NEUROBIOMAT (NBM) is a start-up resulting from pioneering works of R&D on biomaterials for neural tissue engineering carried out by Doctor Stéphane Woerly which aims to provide an innovative solution for repairing the damaged spinal cord. NBM has developed an implantable device - SPINEREP - intended for the functional repair of post-traumatic lesions of the spinal cord through a tissue engineering approach, by targeting the restoration of damaged nervous networks responsible for the transmission of nerve impulses. NBM's know-how and intellectual property are based on a patented technology which shapes polymers into three-dimensional scaffolds. SPINEREP is a flexible and porous, biocompatible polymer biomaterial which, once positioned surgically at the level of the lesion, allows the regrowth of nerve fibers and their connections across the lesion cavity by playing the role of a growth-promoting template as well as neural tissue rebuilding.
NEUROBIOMAT revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
NEUROBIOMAT has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
NEUROBIOMAT has never raised funding before.
NEUROBIOMAT Tech Stack
Discover the technologies and tools that power NEUROBIOMAT's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Issue trackers
Blogs
Miscellaneous
Security
Miscellaneous
JavaScript frameworks
IaaS
CDN
Reverse proxies
Miscellaneous
Performance
Frequently asked questions
4.8
40,000 users



